For research use only
| Cat No. | ABC-X0194C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Host Cell | 293T |
| Source Organ | Kidney |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The Xpress™ Human SIRPA Overexpression Cell Line (293T) is ideal for studying macrophage checkpoint signaling and CD47-SIRPa axis in cancer models.
Human SIRPA 293T Overexpression Cell Line is a genetically engineered model derived from selected human embryonic kidney 293T parental cell line based on customers’ requirement. SIRPA 293T overexpression cell line is generated by stable integration of exogenous human SIRPA into 293T host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT‑PCR.
Target
The SIRPA gene encodes signal regulatory protein α, an immunoglobulin superfamily receptor delivering inhibitory “don’t eat me” signals upon binding CD47. It modulates macrophage phagocytosis, dendritic‑cell activation, and antitumor immunity, with overexpression linked to tumor immune evasion and inflammatory disorders. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0194C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Kidney |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | 293T |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The SIRPA 293T Overexpression Cell Line enables mechanistic studies of the CD47–SIRPA axis, assays of macrophage checkpoint blockade, and high‑throughput screening of anti‑CD47/SIRPA biologics or small‑molecule antagonists in human in‑vitro systems.